# National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following Federal advisory committee meeting.
*Name:* National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect (NTFFASFAE).
*Times and Dates:*
8:30 a.m.-4:30 p.m., September 20, 2002.
8:30 a.m.-12 noon, September 21, 2002.
*Place:* Hyatt Regency, 265 Peachtree Street, N.E., Atlanta, Georgia 30303, telephone 404/577-1234, fax 404/588-3752.
*Status:* Open to the public, limited only by the space available. The meeting room accommodates approximately 65 people.
*Purpose:* The Secretary is authorized by the Public Health Service Act, section 399H, (42 U.S.C. 280f, as added by Public Law 105-392) to establish a National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect to: (1) Foster coordination among all governmental agencies, academic bodies and community groups that conduct or support Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effect (FAE) research, programs and surveillance; and (2) to otherwise meet the general needs of populations actually or potentially impacted by FAS and FAE.
*Matters To Be Discussed:* Discussions will focus on ways the Task Force can collaborate with CDC and other Federal agencies on issues of diagnostic criteria for FAS/Alcohol Related Neurodevelopmental Disorder (ARND) in order to enhance health care providers' recognition of these disorders, and to ensure that those affected and their families receive needed services; the special needs of birth mothers of children with FAS/ARND; a report of the Substance Abuse and Mental Health Services Administration FAS/FAE Center for Excellence on their initial “stakeholders” meetings and future plans; an update on activities from the Interagency Coordinating Committee on Fetal Alcohol Syndrome; new research and program updates from the CDC; and a discussion of the implementation of the Task Force recommendations by various governmental agencies. Additional agenda items include: Working group updates; discussion of future topics, and scheduling the next meeting.
Agenda items are subject to change as priorities dictate.
*Contact Person for More Information:* R. Louise Floyd, DSN, RN, Designated Federal Official, National Center on Birth Defects and Developmental Disabilities, CDC, 4700 Buford Highway, NE, (F-49), Atlanta, Georgia 30333, telephone 770/488-7372, fax 770/488-7361.
The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR.
Dated: August 2, 2002.
John Burckhardt,
Acting Director, Management Analysis and Services Office, , Centers for Disease Control and Prevention.